CD34 and glioblastoma: In the GBM/GBC and BEAM/BEAC groups, the median doses of transplanted CD34+ cells were 2.92 × 106/kg (range, 1.12–21.33) and 3.02 × 106/kg (range, 1.53–18.00), respectively (p = 0.805).